Olanzapine in the Prevention and Treatment of Anorexia-Cachexia Syndrome in Patients Receiving Neoadjuvant/Preoperative Chemotherapy

Clinical trial NCT07633236 · RECRUITING

Trial details

NCT number: NCT07633236
Sponsor: Blokhin's Russian Cancer Research Center
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Oncology Patients Receiving Chemotherapy Cachexia-Anorexia Syndrome Oncology

Start date: 2025-03-28
Primary completion: 2026-12-28
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.